Ultragenyx Pharmaceutical, Inc. (RARE)
14.30
-0.10
(-0.69%)
USD |
NASDAQ |
Sep 11, 16:00
14.30
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Shareholders Equity (Quarterly) : -291.00M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -291.00M |
| March 31, 2026 | -236.00M |
| December 31, 2025 | -80.00M |
| September 30, 2025 | 9.159M |
| June 30, 2025 | 151.29M |
| March 31, 2025 | 144.25M |
| December 31, 2024 | 255.30M |
| September 30, 2024 | 346.83M |
| June 30, 2024 | 432.42M |
| March 31, 2024 | 140.26M |
| December 31, 2023 | 275.41M |
| September 30, 2023 | 31.71M |
| June 30, 2023 | 129.03M |
| March 31, 2023 | 220.48M |
| December 31, 2022 | 352.49M |
| September 30, 2022 | 468.83M |
| June 30, 2022 | 678.07M |
| March 31, 2022 | 796.42M |
| December 31, 2021 | 922.56M |
| September 30, 2021 | 933.67M |
| June 30, 2021 | 972.17M |
| March 31, 2021 | 1.055B |
| December 31, 2020 | 1.154B |
| September 30, 2020 | 666.19M |
| June 30, 2020 | 695.59M |
| Date | Value |
|---|---|
| March 31, 2020 | 609.15M |
| December 31, 2019 | 653.76M |
| September 30, 2019 | 727.26M |
| June 30, 2019 | 819.79M |
| March 31, 2019 | 886.73M |
| December 31, 2018 | 608.91M |
| September 30, 2018 | 662.60M |
| June 30, 2018 | 703.97M |
| March 31, 2018 | 723.66M |
| December 31, 2017 | 383.45M |
| September 30, 2017 | 365.56M |
| June 30, 2017 | 429.45M |
| March 31, 2017 | 488.48M |
| December 31, 2016 | 473.97M |
| September 30, 2016 | 455.89M |
| June 30, 2016 | 443.90M |
| March 31, 2016 | 489.82M |
| December 31, 2015 | 531.09M |
| September 30, 2015 | 576.76M |
| June 30, 2015 | 319.28M |
| March 31, 2015 | 341.12M |
| December 31, 2014 | 184.94M |
| September 30, 2014 | 199.33M |
| June 30, 2014 | 153.08M |
| March 31, 2014 | 165.71M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Biogen, Inc. | 18.85B |
| BioMarin Pharmaceutical, Inc. | 6.322B |
| Ionis Pharmaceuticals, Inc. | 439.74M |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.264B |
| Total Liabilities (Quarterly) | 1.548B |
| Debt to Equity Ratio | -4.131 |
| Current Ratio | 1.726 |
| Net Debt Paydown Yield | -1.90% |